Synergistic Stimulation of Airway Smooth Muscle Cell Mitogenesis1

  1. Tracy L. Ediger and
  2. Myron L. Toews
  1. Department of Pharmacology, University of Nebraska Medical Center, Omaha, Nebraska

    Abstract

    Previous studies showed that human airway smooth muscle (HASM) cells treated with lysophosphatidic acid (LPA), a pertussis toxin (PTX)-sensitive G protein-coupled (GPC) mitogen, simultaneously with epidermal growth factor (EGF), a receptor tyrosine kinase (RTK) mitogen, exhibit markedly synergistic stimulation of mitogenesis. We now show that the RTK mitogens basic fibroblast growth factor, insulin-like growth factor-1, insulin, platelet-derived growth factor-AA, and platelet-derived growth factor-BB, as well as transforming growth factor-β, all induced synergistic stimulation of mitogenesis in the presence of LPA. The PTX-sensitive GPC mitogens carbachol and endothelin-1 and the PTX-insensitive GPC mitogens sphingosine-1-phosphate and thrombin exhibited synergistic stimulation together with EGF. Several RTK-RTK growth factor pairs and GPC-GPC mitogen pairs were also synergistic. HASM cells showed synergistic responses to serum plus EGF but not to serum plus LPA. Testing various other cell types showed that synergism between LPA and EGF occurred in other smooth muscle cells because both vascular smooth muscle cells and mesangial cells exhibited synergism. Additionally, human fetal lung fibroblasts also showed striking synergism. These results indicate that HASM cells can respond synergistically to a wide variety of mitogen combinations and that this synergism is a feature shared with other contractile cell types.

    Footnotes

    • Send reprint requests to: Myron L. Toews, Ph.D. Department of Pharmacology, 986260 Nebraska Medical Center, Omaha, NE 68198-6260. E-mail: mtoews{at}unmc.edu

    • 1 This work was supported in part by research seed grants from the University of Nebraska Medical Center (to M.L.T.) and a University of Nebraska Medical Center McDonald Fellowship (to T.L.E).

    • Abbreviations:
      LPA
      lysophosphatidic acid
      GPC
      G protein-coupled
      EGF
      epidermal growth factor
      RTK
      receptor tyrosine kinase
      HASM
      human airway smooth muscle
      FGF
      fibroblast growth factor
      PDGF
      platelet-derived growth factor
      DMEM
      Dulbecco's modified Eagle's medium
      FBS
      fetal bovine serum
      bFGF
      basic fibroblast growth factor
      TGF-β
      transforming growth factor-β
      PTX
      pertussis toxin
      IGF-1
      insulin-like growth factor-1
      HFL-1
      human fetal lung fibroblasts
      HFF
      human foreskin fibroblasts
      VSM
      vascular smooth muscle
      HMC
      human mesangial cell
      S1P
      sphingosine-1-phosphate
      CCh
      carbachol
      ET-1
      endothelin-1
      • Received January 6, 2000.
      • Accepted May 9, 2000.
    « Previous | Next Article »Table of Contents